Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP)

baseline characteristics and trends observed in diabetic nephropathy

Manabu Hishida, Hirofumi Tamai, Takatoshi Morinaga, Michitaka Maekawa, Takafumi Aoki, Hidetaka Tomida, Shintaro Komatsu, Tomoaki Kamiya, Shoichi Maruyama, Seiichi Matsuo, Daijo Inaguma

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Over 300,000 patients receive maintenance dialysis in Japan; managing these patients is extremely important. This study aimed to report on prior management of chronic kidney diseases and prognostication after dialysis initiation. Patients and methods: Seventeen institutions participated in the Aichi cohort study of prognosis in patients newly initiated into dialysis and recruited patients over a period of 2 years. Exclusion criteria were (1) patients under 20 years; (2) patients who died before hospital discharge; and (3) patients who could not provide consent. Result: Here, we showed data on dialysis initiation time. Of 1524 patients with mean age of 67.5 ± 13.0 years, 659 patients were put on dialysis following diabetic nephropathy diagnosis. At dialysis initiation time, creatinine and estimated glomerular filtration rate levels were 8.97 ± 3.21 mg/dl and 5.45 ± 2.22 ml/min/1.73 m2, respectively. Medications taken were angiotensin II receptor blockers in 866; angiotensin-converting enzyme inhibitors in 135; calcium antagonist in 1202; and diuretics, alone or in combination, in 1059. Among patients with diabetic nephropathy, many had increased body weight and systolic blood pressure and were taking loop and thiazide diuretics at dialysis initiation time. Many patients with diabetic nephropathy had coronary artery disease and percutaneous coronary intervention. Conclusion: Many patients with diabetic nephropathy who registered for this study had coronary artery disease and problems with excess body fluid. Further analyses may clarify how underlying conditions and disease management before and after dialysis initiation affect prognosis.

Original languageEnglish
Pages (from-to)795-807
Number of pages13
JournalClinical and Experimental Nephrology
Volume20
Issue number5
DOIs
Publication statusPublished - 01-10-2016
Externally publishedYes

Fingerprint

Diabetic Nephropathies
Dialysis
Cohort Studies
Coronary Artery Disease
Blood Pressure
Sodium Potassium Chloride Symporter Inhibitors
Sodium Chloride Symporter Inhibitors
Angiotensin Receptor Antagonists
Body Fluids
Percutaneous Coronary Intervention
Disease Management
Glomerular Filtration Rate
Chronic Renal Insufficiency
Angiotensin-Converting Enzyme Inhibitors
Diuretics
Creatinine
Japan
Body Weight
Maintenance

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Physiology (medical)

Cite this

Hishida, Manabu ; Tamai, Hirofumi ; Morinaga, Takatoshi ; Maekawa, Michitaka ; Aoki, Takafumi ; Tomida, Hidetaka ; Komatsu, Shintaro ; Kamiya, Tomoaki ; Maruyama, Shoichi ; Matsuo, Seiichi ; Inaguma, Daijo. / Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP) : baseline characteristics and trends observed in diabetic nephropathy. In: Clinical and Experimental Nephrology. 2016 ; Vol. 20, No. 5. pp. 795-807.
@article{2f3a823b57c54e1a878575713a2a0199,
title = "Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy",
abstract = "Background: Over 300,000 patients receive maintenance dialysis in Japan; managing these patients is extremely important. This study aimed to report on prior management of chronic kidney diseases and prognostication after dialysis initiation. Patients and methods: Seventeen institutions participated in the Aichi cohort study of prognosis in patients newly initiated into dialysis and recruited patients over a period of 2 years. Exclusion criteria were (1) patients under 20 years; (2) patients who died before hospital discharge; and (3) patients who could not provide consent. Result: Here, we showed data on dialysis initiation time. Of 1524 patients with mean age of 67.5 ± 13.0 years, 659 patients were put on dialysis following diabetic nephropathy diagnosis. At dialysis initiation time, creatinine and estimated glomerular filtration rate levels were 8.97 ± 3.21 mg/dl and 5.45 ± 2.22 ml/min/1.73 m2, respectively. Medications taken were angiotensin II receptor blockers in 866; angiotensin-converting enzyme inhibitors in 135; calcium antagonist in 1202; and diuretics, alone or in combination, in 1059. Among patients with diabetic nephropathy, many had increased body weight and systolic blood pressure and were taking loop and thiazide diuretics at dialysis initiation time. Many patients with diabetic nephropathy had coronary artery disease and percutaneous coronary intervention. Conclusion: Many patients with diabetic nephropathy who registered for this study had coronary artery disease and problems with excess body fluid. Further analyses may clarify how underlying conditions and disease management before and after dialysis initiation affect prognosis.",
author = "Manabu Hishida and Hirofumi Tamai and Takatoshi Morinaga and Michitaka Maekawa and Takafumi Aoki and Hidetaka Tomida and Shintaro Komatsu and Tomoaki Kamiya and Shoichi Maruyama and Seiichi Matsuo and Daijo Inaguma",
year = "2016",
month = "10",
day = "1",
doi = "10.1007/s10157-015-1206-z",
language = "English",
volume = "20",
pages = "795--807",
journal = "Clinical and Experimental Nephrology",
issn = "1342-1751",
publisher = "Springer Japan",
number = "5",

}

Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP) : baseline characteristics and trends observed in diabetic nephropathy. / Hishida, Manabu; Tamai, Hirofumi; Morinaga, Takatoshi; Maekawa, Michitaka; Aoki, Takafumi; Tomida, Hidetaka; Komatsu, Shintaro; Kamiya, Tomoaki; Maruyama, Shoichi; Matsuo, Seiichi; Inaguma, Daijo.

In: Clinical and Experimental Nephrology, Vol. 20, No. 5, 01.10.2016, p. 795-807.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP)

T2 - baseline characteristics and trends observed in diabetic nephropathy

AU - Hishida, Manabu

AU - Tamai, Hirofumi

AU - Morinaga, Takatoshi

AU - Maekawa, Michitaka

AU - Aoki, Takafumi

AU - Tomida, Hidetaka

AU - Komatsu, Shintaro

AU - Kamiya, Tomoaki

AU - Maruyama, Shoichi

AU - Matsuo, Seiichi

AU - Inaguma, Daijo

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Background: Over 300,000 patients receive maintenance dialysis in Japan; managing these patients is extremely important. This study aimed to report on prior management of chronic kidney diseases and prognostication after dialysis initiation. Patients and methods: Seventeen institutions participated in the Aichi cohort study of prognosis in patients newly initiated into dialysis and recruited patients over a period of 2 years. Exclusion criteria were (1) patients under 20 years; (2) patients who died before hospital discharge; and (3) patients who could not provide consent. Result: Here, we showed data on dialysis initiation time. Of 1524 patients with mean age of 67.5 ± 13.0 years, 659 patients were put on dialysis following diabetic nephropathy diagnosis. At dialysis initiation time, creatinine and estimated glomerular filtration rate levels were 8.97 ± 3.21 mg/dl and 5.45 ± 2.22 ml/min/1.73 m2, respectively. Medications taken were angiotensin II receptor blockers in 866; angiotensin-converting enzyme inhibitors in 135; calcium antagonist in 1202; and diuretics, alone or in combination, in 1059. Among patients with diabetic nephropathy, many had increased body weight and systolic blood pressure and were taking loop and thiazide diuretics at dialysis initiation time. Many patients with diabetic nephropathy had coronary artery disease and percutaneous coronary intervention. Conclusion: Many patients with diabetic nephropathy who registered for this study had coronary artery disease and problems with excess body fluid. Further analyses may clarify how underlying conditions and disease management before and after dialysis initiation affect prognosis.

AB - Background: Over 300,000 patients receive maintenance dialysis in Japan; managing these patients is extremely important. This study aimed to report on prior management of chronic kidney diseases and prognostication after dialysis initiation. Patients and methods: Seventeen institutions participated in the Aichi cohort study of prognosis in patients newly initiated into dialysis and recruited patients over a period of 2 years. Exclusion criteria were (1) patients under 20 years; (2) patients who died before hospital discharge; and (3) patients who could not provide consent. Result: Here, we showed data on dialysis initiation time. Of 1524 patients with mean age of 67.5 ± 13.0 years, 659 patients were put on dialysis following diabetic nephropathy diagnosis. At dialysis initiation time, creatinine and estimated glomerular filtration rate levels were 8.97 ± 3.21 mg/dl and 5.45 ± 2.22 ml/min/1.73 m2, respectively. Medications taken were angiotensin II receptor blockers in 866; angiotensin-converting enzyme inhibitors in 135; calcium antagonist in 1202; and diuretics, alone or in combination, in 1059. Among patients with diabetic nephropathy, many had increased body weight and systolic blood pressure and were taking loop and thiazide diuretics at dialysis initiation time. Many patients with diabetic nephropathy had coronary artery disease and percutaneous coronary intervention. Conclusion: Many patients with diabetic nephropathy who registered for this study had coronary artery disease and problems with excess body fluid. Further analyses may clarify how underlying conditions and disease management before and after dialysis initiation affect prognosis.

UR - http://www.scopus.com/inward/record.url?scp=84959125610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959125610&partnerID=8YFLogxK

U2 - 10.1007/s10157-015-1206-z

DO - 10.1007/s10157-015-1206-z

M3 - Article

VL - 20

SP - 795

EP - 807

JO - Clinical and Experimental Nephrology

JF - Clinical and Experimental Nephrology

SN - 1342-1751

IS - 5

ER -